Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants
about
The Autoimmune EcologyUnmet needs of patients with narcolepsy: perspectives on emerging treatment optionsFraming post-pandemic preparedness: Comparing eight European plans.Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responsesHistory of narcolepsy at Stanford University.System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test.Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.Mechanistic insights into influenza vaccine-associated narcolepsy.Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature.Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells.No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future NeedsA fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.Adversomics: a new paradigm for vaccine safety and design.Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.Narcolepsy in African Americans.Harnessing the beneficial heterologous effects of vaccination.T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity.Challenges in the development of therapeutics for narcolepsy.Adjuvants- and vaccines-induced autoimmunity: animal models.Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response.Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction.Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice.Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.[Narcolepsy with cataplexy: an autoimmune disease?].Vaccination and narcolepsy: Immune link found?Is it Time for Immunotherapy Trials in Narcolepsy?Spontaneous reporting of suspected narcolepsy after vaccination against pandemic influenza A (H1N1) in Germany.The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism.Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.Influence of hydrocarbon oil structure on adjuvanticity and autoimmunity.AS03- and MF59-Adjuvanted Influenza Vaccines in Children.CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1.Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling.MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses.
P2860
Q26747427-A0084F96-72AB-4D3E-A9B3-7D278B85D506Q26827736-1E2DE7F5-B564-44F7-B588-D1AB56A13255Q30196458-8DD106C1-4CAC-4F99-A25B-1C7913EEAE42Q30205195-E1F6C46C-6E8A-423C-A425-C43C4DF00B82Q30362536-DE6ABCB0-D6E1-468F-88FF-94C087FE82A9Q30364552-EDD33394-63B1-40E8-B5C2-3D940FA83FFFQ30367259-E91C84A4-32B9-4780-AE68-B7A8E2D65D60Q30376254-7D10727E-E7D2-440C-A1BF-6F25B0DF237FQ30386044-2D78DA1F-AFFF-49AC-A708-7A9BABD29CFBQ30386292-371B4679-883F-4279-82C3-41A81C282FF3Q33607120-B9C0281B-FF5A-4E90-9D69-EC790928E79AQ34621859-38835CA1-F617-4D87-A237-A2D769CDEDC2Q35434746-DC0B9C93-8A33-4DA0-A859-DD6E7DE91FDDQ36000839-4564098E-7447-48FB-8C2A-447C95E29B04Q36191001-07DFAD0C-78A8-4BEC-94DE-5B43ECDA45D2Q36240389-37893433-1A56-4B6A-A748-30E8F9E03C99Q36242667-B0D36DE9-A707-46B1-8D7A-5977238B7DF1Q36255408-19A3F232-FD64-4618-B32E-D05F4E67323AQ36744152-7FC16726-B84D-463F-A4A9-E843CE2F4D0EQ37061098-F7D4D739-736A-4EAC-9796-CACD358CBEEFQ38640293-1F71BBEF-5D41-41FD-85DD-4559DD4EDDD6Q38684472-B633847A-C588-49B5-BEF7-5DBD87881C52Q38841755-43617568-DF6F-4068-8A5A-CABB0ACE10BFQ38867876-6C824BD6-4C95-441A-8901-9A637C33C691Q40116011-4C1BB7DF-3E2B-4E2C-B7B2-44AAAB43425AQ40278805-17138E3C-13DA-4ABB-AFAF-0256FBEBF196Q40597501-CCC94ABF-6CB1-4897-A618-B1F2CC8D828EQ41118592-74E34ACE-EBB9-4E1B-94F5-9270D10CA7AFQ41583882-E545E92C-9F7D-4F53-8D1C-7278E4C0E457Q41619520-99E19A58-C9EF-4A32-9F57-D65F6E617728Q41732462-74A4D59B-27E5-4797-BFD8-6301CDD487A3Q42005677-104914BC-B82F-43D7-A448-F8E6A111FF4AQ42340206-3F836338-23DF-4500-B48B-A166FD0FDFB8Q46128712-99CCFCEB-1B2D-4544-A565-DB833BA95091Q47151298-FF4D25BC-9B9A-44A1-A02C-96A9A72AA405Q47658890-0B20134E-491A-4AD7-BC3A-985F5A6CDC48Q47748099-8AA1DFD0-017C-407B-9B4B-36A457F2BA91Q49961724-DD6DEC53-A339-4A73-A6B4-B82A7B2B59E9Q50024815-F340A9E2-8CF6-48D2-9829-078890BA636BQ52726414-A2294CF1-302D-43A5-AE9A-BC4D8485469C
P2860
Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@ast
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@en
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@nl
type
label
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@ast
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@en
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@nl
prefLabel
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@ast
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@en
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@nl
P2093
P921
P3181
P1476
Narcolepsy, 2009 A(H1N1) pande ...... mmunity, and vaccine adjuvants
@en
P2093
Lawrence Steinman
Peter H. Schur
S. Sohail Ahmed
P3181
P356
10.1016/J.JAUT.2014.01.033
P407
P577
2014-05-01T00:00:00Z